Drugs / EV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04815213 | Jan 2022 → Jan 2025 overdue | primary ovarian failure | University of Jordan | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04815213 ↗ |
| Modality | Other / unclassified | “Extracellular vesicles injection” NCT04815213 ↗ |